WallStreetZenWallStreetZen

NASDAQ: ALT
Altimmune Inc Stock

Open Broker Account
$12.00-1.00 (-7.69%)
Updated Oct 5, 2022
ALT Price
$12.00
Fair Value Price
$14.86
Market Cap
$582.42M
52 Week Low
$3.83
52 Week High
$23.49
P/E
-5.38x
P/B
2.99x
P/S
159.93x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.48M
Earnings
-$96.94M
Gross Margin
100%
Operating Margin
-2,786.54%
Profit Margin
-2,789.4%
Debt to Equity
0.08
Operating Cash Flow
-$70M
Beta
0.36
Next Earnings
Nov 7, 2022
Ex-Dividend
N/A
Next Dividend
N/A

ALT Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ALT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ALT ($12.00) is undervalued by 19.25% relative to our estimate of its Fair Value price of $14.86 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ALT ($12.00) is not significantly undervalued (19.25%) relative to our estimate of its Fair Value price of $14.86 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ALT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ALT due diligence checks available for Premium users.

Be the first to know about important ALT news, forecast changes, insider trades & much more!

ALT News

Valuation

ALT fair value

Fair Value of ALT stock based on Discounted Cash Flow (DCF)
Price
$12.00
Fair Value
$14.86
Undervalued by
19.25%
ALT ($12.00) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ALT ($12.00) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ALT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ALT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-5.38x
Industry
16.06x
Market
28.61x

ALT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.99x
Industry
4.51x
ALT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ALT's financial health

Profit margin

Revenue
$8.0k
Net Income
-$20.1M
Profit Margin
-251,337.5%
ALT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ALT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$209.9M
Liabilities
$15.4M
Debt to equity
0.08
ALT's short-term assets ($195.50M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ALT's short-term assets ($195.50M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ALT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ALT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$16.7M
Investing
-$49.0M
Financing
$21.6M
ALT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ALT vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ALT$582.42M-7.69%-5.38x2.99x
VNDA$584.85M+0.49%49.24x1.15x
VRDN$585.50M-1.01%-5.14x4.13x
IPSC$589.41M+0.91%-5.21x1.65x
JANX$589.95M+3.13%-11.06x1.72x

Altimmune Stock FAQ

What is Altimmune's quote symbol?

NASDAQ: ALT) Altimmune trades on the NASDAQ under the ticker symbol ALT. Altimmune stock quotes can also be displayed as NASDAQ: ALT.

If you're new to stock investing, here's how to buy Altimmune stock.

What is the 52 week high and low for Altimmune (NASDAQ: ALT)?

(NASDAQ: ALT) Altimmune's 52-week high was $23.49, and its 52-week low was $3.83. It is currently -48.91% from its 52-week high and 213.32% from its 52-week low.

How much is Altimmune stock worth today?

(NASDAQ: ALT) Altimmune currently has 48,535,230 outstanding shares. With Altimmune stock trading at $12.00 per share, the total value of Altimmune stock (market capitalization) is $582.42M.

Altimmune stock was originally listed at a price of $2,100.00 in Oct 6, 2005. If you had invested in Altimmune stock at $2,100.00, your return over the last 16 years would have been -99.43%, for an annualized return of -27.59% (not including any dividends or dividend reinvestments).

How much is Altimmune's stock price per share?

(NASDAQ: ALT) Altimmune stock price per share is $12.00 today (as of Oct 5, 2022).

What is Altimmune's Market Cap?

(NASDAQ: ALT) Altimmune's market cap is $582.42M, as of Oct 6, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Altimmune's market cap is calculated by multiplying ALT's current stock price of $12.00 by ALT's total outstanding shares of 48,535,230.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.